Nicotinic receptor antagonists are compounds that block the action of acetylcholine and nicotine on nicotinic receptors. By inhibiting these receptors, these antagonists can disrupt the signaling pathways that contribute to cancer cell survival, proliferation, and metastasis. Some well-known nicotinic receptor antagonists include mecamylamine, hexamethonium, and various experimental drugs.
